Top Markets
Coin of the day
Neumora Therapeutics, Inc. Common Stock Neumora Therapeutics, Inc. Common Stock

Neumora Therapeutics, Inc. Common Stock

NMRA
Ранг среди акций #17294
Neumora Therapeutics, Inc. is a specialized biopharmaceutical company... Neumora Therapeutics, Inc. is a specialized biopharmaceutical company progressing through clinical trials, dedicated to advancing therapies for a range of neurological, psychiatric, and neurodegenerative conditions. Its most advanced candidate, navacaprant (also known as NMRA-140), is a novel, once-daily oral kappa opioid receptor antagonist currently undergoing Phase 3 clinical trials for the management of major depressive disorder. Additionally, NMRA-511 is in Phase 1 studies, targeting agitation experienced by individuals with Alzheimer's-related dementia. Another compound, NMRA-266, is also in Phase 1 clinical development, aimed at addressing schizophrenia and other related neuropsychiatric conditions. Beyond its clinical programs, Neumora maintains a preclinical pipeline featuring several promising candidates: NMRA-NMDA for schizophrenia, NMRA-CK1d (a CK1d inhibitor initiative) for amyotrophic lateral sclerosis (ALS), NMRA-NLRP3 for specific neurodegenerative ailments, and NMRA-GCase for Parkinson's disease. Tracing its origins to a 2019 incorporation, the company, initially known as RBNC Therapeutics, Inc., adopted its current name, Neumora Therapeutics, Inc., in October 2021. Its corporate headquarters are situated in Watertown, Massachusetts.
Цена акции
$1.38
Рыночная капитализация
$255.69M
Изменение (1 день)
3.76%
Изменение (1 год)
-20.69%
Страна
US
Торговля Neumora Therapeutics, Inc. Common Stock (NMRA)

Категория

История цены акций Neumora Therapeutics, Inc. Common Stock (NMRA)
Наивысшая цена закрытия: $1.35 2026-09-01

Наименьшая цена закрытия: $12.50 2023-09-01
История цены акций Neumora Therapeutics, Inc. Common Stock с 2023 по 2026
Годовая динамика цены акций
Год Результативность
2026 (TTM) 4.72%
2025 -81.20%
2024 -26.84%
2023 0.00%
Цена акций похожих компаний или конкурентов
Компания Цена акций Изменение 1г% Страна
$550.65 37.32%
US
$1.05K 48.27%
NL
$148.50 513.89%
US
$122.21 -10.03%
AU
$763.69 9.05%
CH